AGS subjects carrying TREX1 mutations can present with SLE manifestations such as cytopenia, cutaneous lesions, oral ulcers, and arthritis, as well as positive autoantibodies (ANA, ENA, and anti-dsDNA) (135). Here, TREX1 is linked to systemic lupus erythematosus.